Literature DB >> 6362749

Establishment of a new peroxidase-positive human myeloid cell line, PL-21.

I Kubonishi, K Machida, K Niiya, H Sonobe, Y Ohtsuki, K Iwata, I Miyoshi.   

Abstract

A myeloid cell line, designated PL-21, was established from the peripheral blood of a patient with acute promyelocytic leukemia. The PL-21 cell line grew in single-cell suspension, with a doubling time of 48-64 hr, and consisted of promyelocytes with fine immature nuclei and prominent azurophilic granules in the cytoplasm. PL-21 cells were positive for peroxidase, naphthol AS-D chloroacetate esterase, and Sudan Black B staining. Under the usual culture conditions, a small proportion of these cells differentiated into mature granulocytes, and this differentiation was enhanced by the addition of dimethyl sulfoxide in the culture medium. PL-21 cells had receptors for the Fc portion of IgG and complement, intracytoplasmic lysozyme and phagocytic activity, but lacked Epstein-Barr virus-associated nuclear antigen. Chromosome analysis of this cell line revealed a human male polyploid karyotype with 13q+ and double minute chromosomes. This new myeloid cell line may provide useful material for the study of proliferation and differentiation of human leukemia cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6362749

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Use of HL-60 cell line to measure opsonic capacity of pneumococcal antibodies.

Authors:  R A Fleck; S Romero-Steiner; M H Nahm
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

2.  Synergistic effect of arsenic trioxide and flt3 inhibition on cells with flt3 internal tandem duplication.

Authors:  Shinichiro Takahashi; Hideo Harigae; Hisayuki Yokoyama; Izumi Ishikawa; Shouri Abe; Masue Imaizumi; Takeshi Sasaki; Mitsuo Kaku
Journal:  Int J Hematol       Date:  2006-10       Impact factor: 2.490

3.  Stimulatory effect of interleukin-1 beta on the interferon-gamma-dependent HLA-DR production.

Authors:  T Tomoda; T Kurashige; T Taniguchi
Journal:  Immunology       Date:  1992-05       Impact factor: 7.397

4.  Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations.

Authors:  Tadayuki Akagi; Lee-Yung Shih; Motohiro Kato; Norihiko Kawamata; Go Yamamoto; Masashi Sanada; Ryoko Okamoto; Carl W Miller; Der-Cherng Liang; Seishi Ogawa; H Phillip Koeffler
Journal:  Blood       Date:  2008-12-23       Impact factor: 22.113

5.  Electron microscopic and immunohistochemical observations of differentiation of human myeloid leukemia line, PL-21.

Authors:  I Kubonishi; Y Ohtsuki; T Miyagi; S Yoshimoto; T Akagi; I Miyoshi
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

6.  CD70/CD27 signaling promotes blast stemness and is a viable therapeutic target in acute myeloid leukemia.

Authors:  Carsten Riether; Christian M Schürch; Elias D Bührer; Magdalena Hinterbrandner; Anne-Laure Huguenin; Sabine Hoepner; Inti Zlobec; Thomas Pabst; Ramin Radpour; Adrian F Ochsenbein
Journal:  J Exp Med       Date:  2016-12-28       Impact factor: 14.307

7.  Potentiation of growth-inhibitory activity of 9-beta-D-arabinofuranosyladenine by 2'-deoxycoformycin in human cultured cell lines derived from leukemias and lymphomas.

Authors:  Y Kuroki; M Shimoyama; S Inaba; M Hirose
Journal:  Jpn J Cancer Res       Date:  1989-05

8.  Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16.

Authors:  Y Ishida; T Ohtsu; H Hamada; Y Sugimoto; K Tobinai; K Minato; T Tsuruo; M Shimoyama
Journal:  Jpn J Cancer Res       Date:  1989-10

9.  MicroRNA-150 expression induces myeloid differentiation of human acute leukemia cells and normal hematopoietic progenitors.

Authors:  Valerie A Morris; Ailin Zhang; Taimei Yang; Derek L Stirewalt; Ranjani Ramamurthy; Soheil Meshinchi; Vivian G Oehler
Journal:  PLoS One       Date:  2013-09-24       Impact factor: 3.240

10.  A monoclonal antibody that recognizes a common antigen in myeloid and human T-cell leukemia virus type I-carrying cells.

Authors:  T Takeuchi; I Kubonishi; K Takahashi; Y Ohtsuki; H Taguchi; I Miyoshi
Journal:  Jpn J Cancer Res       Date:  1988-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.